Swiss Re declares significant net loss in full-year results

spike

The group’s property and casualty reinsurance arm saw a net loss of US$247 million last year, excluding COVID this would have been a net income of US$1.3 billion, and a combined ratio of 109{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f}, up from 107.8{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} in 2019. The reinsurer revealed that price increases of 6.5{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} achieved in January 2021 renewals and a focus on portfolio quality are showing an improved 2021 normalised combined ratio of less than 95{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f}.

Swiss Re’s life and health reinsurance arm posted a net income of US$71 million for 2020 and the company stated its Corporate Solutions turnaround was ahead of plan with a net loss of US$350 million, an improvement on 2019’s net loss of US$647 million. Its Life Capital business showed a net loss of US$265 million and the successful closure of its ReAssure sale delivered a dividend of US$1.5 billion for the group.

Based on these results, the board of directors will propose a dividend of CHF 5.90 per share at its AGM on April 16, 2021. Swiss Re has also decided to replace its 220{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} Group SST target ratio with a target range of 200–250{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f}.

Swiss Re’s group CEO Christian Mumenthaler emphasised the global impact of the COVID crisis and said the group has played its role as a shock absorber with confidence and strength. He noted that the reinsurer took a prudent approach at the start of the pandemic to build reserves as claims have been slow to come in and that, while further COVID losses are expected in 2021, the business has significantly reduced relevant exposures in P&C lines.

“I am very encouraged by broad-based improvements in portfolio quality and underwriting margins in P&C Re and Corporate Solutions, including in the January renewals,” he said.

Swiss Re stated it expects additional COVID-19-related claims and reserves in its P&C businesses of less than US$0.5 billion in 2021, based on current information, but noted that with so much uncertainty, actual claims developments could be impacted either positively or negatively.

Swiss Re’s group CFO John Dacey said: “Our capital position remained very strong throughout 2020, despite the unprecedented impact from COVID-19 and an unusually high frequency of natural catastrophes. Swiss Re’s businesses continued to run without disruptions, delivering a strong underlying performance. Together with a positive outlook, this allows us to propose a stable dividend payment to our shareholders even in these challenging times.”

Source Article

Next Post

Partner Re brings in new board member

Partner Re has announced that it has appointed Enrico Vellano (pictured) to its board of directors. Vellano succeeds John Elkann as Exor’s representative. Vellano is the chief financial officer of Exor, the owner of Partner Re. He began his career in 1997 at IFIL, the investment company controlled by the […]